Impact of Omega-3 Fatty Acids on the Gut Microbiota
Open accessThe DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Abstract
Long-term dietary habits play a crucial role in creating a host-specific gut microbiota community in humans. Despite the many publications about the effects of carbohydrates (prebiotic fibers), the impact of dietary fats, such as omega-3 polyunsaturated fatty acids (PUFAs), on the gut microbiota is less well defined. The few studies completed in adults showed some common changes in the gut microbiota after omega-3 PUFA supplementation. In particular, a decrease in Faecalibacterium, often associated with an increase in the Bacteroidetes and butyrate-producing bacteria belonging to the Lachnospiraceae family, has been observed. Coincidentally, a dysbiosis of these taxa is found in patients with inflammatory bowel disease. Omega-3 PUFAs can exert a positive action by reverting the microbiota composition in these diseases, and increase the production of anti-inflammatory compounds, like short-chain fatty acids. In addition, accumulating evidence in animal model studies indicates that the interplay between gut microbiota, omega-3 fatty acids, and immunity helps to maintain the intestinal wall integrity and interacts with host immune cells. Finally, human and animal studies have highlighted the ability of omega-3 PUFAs to influence the gut–brain axis, acting through gut microbiota composition. From these findings, the importance of the omega-3 connection to the microbiota emerges, encouraging further studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Omega-3 polyunsaturated fatty acid (PUFA) potential action in restoring eubiosis in gut microbiota. Dysbiosis of the Firmicutes/Bacteroidetes ratio is associated with several conditions, such as weight gain and obesity [56], insulin resistance [56], high-fat diet [38,39], gut permeability [54], IBDs [21], and depression [88]. Similarly, a Bifidobacteria decrease combined with a Enterobacteria increase leads to the establishment of endotoxemia that causes a chronic low-grade inflammation associated with some pathological conditions, like insulin resistance [46], gut permeability [43,44], and depression [92]. Initial evidence shows that omega-3 PUFAs are able to reverse this condition by restoring the Firmicutes/Bacteroidetes ratio, and increasing Lachnospiraceae taxa [13,16,18,19,20], both associated with an increased production of the anti-inflammatory short-chain fatty acid (SCFA) butyrate [13,19,20]. Moreover, animal studies showed the ability of omega-3 PUFAs to increase lipopolysaccharide (LPS)-suppressing bacteria, Bifidobacteria, and to decrease LPS-producing bacteria, Enterobacteria, negating the endotoxemia phenomenon [52]. For all these actions, omega-3 PUFAs can be considered as prebiotics, able to restore gut eubiosis in some pathological conditions.](https://figures.cochat.ai/paper-figures/ca053c2581704759a2692cd08c7a55a9/impact-of-omega-3-fatty-acids-on-the-gut-microbiota-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Omega-3 supplementation has also been proven to impact the development and composition of gut microbiota positively.”
From Microalgae n-3 PUFAs Production and Use in Food and Feed Industries (2021) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, ω-3 fatty acids have been proposed to restore the eubiotic state in pathological conditions by increasing the beneficial bifidobacteria and decreasing enterobacteria, which in turn supports an anti-inflammatory environment through the production of SCFAs and suppression of endotoxemia (81,141).”
From Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health (2021) · cites this paper as [141]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The nature of dietary fats influences the types and number of gut microbes and the host’s intestinal health [36].”
From Microalgae n-3 PUFAs Production and Use in Food and Feed Industries (2021) · cites this paper as [36]
In the citing paper
“Furthermore, the health benefits of EPA and DHA, such as their antimicrobial activities, can be triggered by intestinal microbiota’s enzymatic actions [36].”
From Microalgae n-3 PUFAs Production and Use in Food and Feed Industries (2021) · cites this paper as [36]
In the citing paper
“Theoretically, combining probiotics with omega-3 fatty acids may offer a promising nutritional strategy to counteract metabolic challenges associated with aging via the gut microbiota, especially relevant for older people that suffer from anabolic resistance, systemic inflammation, and mood disorders (through the gut–brain axis) [279,294,295].”
From Nutrition for Older Athletes: Focus on Sex-Differences (2021) · cites this paper as [295]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“These genes have been estimated to belong to approximately 1013–1014 microbes, with a species diversity of up to several hundred per individual [1].”
BackgroundDiet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“The increase of Akkermansia muciniphila improves the barrier function and glucose metabolism, and also decreases macrophage infiltration in the white adipose tissue (WAT) [58].”
BackgroundThe gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · cited 1×
“Studies on germ-free mice have shown that the lack of intestinal microbiota leads to the reduced development of the intestinal immune system and oral tolerance [29].”
BackgroundFrank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 1×
“Furthermore, long-term EPA/DHA administration in separated mice improved the inflammatory condition typically associated with stress by increasing the abundance of butyrate-producing bacteria and decreasing the levels of pro-inflammatory bacterial genera, such as Akkermansia and Flexibacter, which have been reported t…”
BackgroundMind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572 · cited 1×
“Through this axis, the gut microbiota and central nervous system (CNS) communicate by different pathways, including endocrine, immune, and neural pathways, using the gastrointestinal tract as a scaffold [86].”
BackgroundSilverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409 · cited 1×
“In IBD, the prolonged activation of NF-κB leads to the production of pro-inflammatory cytokines [80].”
BackgroundFormation of propionate and butyrate by the human colonic microbiota
Louis, P., & Flint, H. J. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13589 · Cited by 3,028 · cited 3×
“A statistically increased abundance of Bifidobacterium and Oscillospira genera, associated with a reduction of Coprococcus and Faecalibacterium, were found after both omega-3 PUFA supplementations in comparison with before the study and after washout.”
BackgroundInfluentialMicrobial degradation of complex carbohydrates in the gut
Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P., & Forano, E. (2012) · Gut Microbes · doi:10.4161/gmic.19897 · Cited by 2,331 · cited 1×
“This gut community has many degrading enzymes and metabolic capabilities that are able to break down macromolecules into smaller chemical compounds, which can then be uptaken by enterocytes [4].”
BackgroundAltered fecal microbiota composition in patients with major depressive disorder
Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., et al. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.016 · Cited by 2,275 · cited 2×
“Dysbiosis of the Firmicutes/Bacteroidetes ratio is associated with several conditions, such as weight gain and obesity [56], insulin resistance [56], high-fat diet [38,39], gut permeability [54], IBDs [21], and depression [88].”
Background
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Gut Microbiome: Profound Implications for Diet and Disease
Hills, R., Pontefract, B., Mishcon, H., Black, C., Sutton, S., & Theberge, C. (2019) · Nutrients · doi:10.3390/nu11071613 · Cited by 1,092
Nogal, A., Valdes, A. M., & Menni, C. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1897212 · Cited by 917
“consumption of fiber-rich food, or omega-3-rich diets, has been correlated with higher levels of SCFAs and SCFA-producing bacteria.(18,19) Previous reviews addressed SCFAs, CMD or, diet and their links to gut microbiome composition, however none of them has yet simultaneously covered the role of SCFAs in the interplay…”
BackgroundMilosevic, I., Vujovic, A., Barac, A., Djelic, M., Korac, M., Radovanovic Spurnic, A., Gmizic, I., Stevanovic, O., Djordjevic, V., Lekic, N., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020395 · Cited by 551
“Lastly, the n-3 PUFAs administration has been related to an increment of butyrate-producing bacteria [94].”
BackgroundGut microbiome lipid metabolism and its impact on host physiology
Brown, E. M., Clardy, J., & Xavier, R. J. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.01.009 · Cited by 447
Metadata
- Authors
- Costantini, L., Molinari, R., Farinon, B., & Merendino, N.
- Affiliations
- Università degli Studi della Tuscia (IT)
- Corresponding author
- Merendino, Nicolò
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-12-07
- Volume
- 18
- Issue
- 12
- Pages
- 2645
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5751248
- OpenAlex
- W2772974937
- Cited by
- 741
- References
- 105
- Citations by year
- 2026: 60 · 2025: 109 · 2024: 93 · 2023: 93 · 2022: 121 · 2021: 100 · 2020: 88 · 2019: 57 · 2018: 20
- Type
- dissertation
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UnitusOpen (Tuscia University) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- omega-3 fatty acids, polyunsaturated fatty acids, gut microbiota, dietary fat, Faecalibacterium, Bacteroidetes, Lachnospiraceae, butyrate-producing bacteria, dysbiosis, inflammatory bowel disease, short-chain fatty acids, intestinal barrier integrity, host immunity, gut-brain axis
- MeSH terms
- Gastrointestinal Microbiome, Animals, Humans, Fatty Acids, Omega-3, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.